فهرست مطالب:

1 RNA and CRISPR Interferences: Past, Present, and Future
Perspectives
2 Chemical Modiϐications in RNA Interference and CRISPR/ Cas
Genome Editing Reagents
3 Preparation, Determination of Activity, and Biodistribution of
Cholesterol-Containing Nuclease-Resistant siRNAs In Vivo
4 Multifunctional Nanodelivery Platform for Maximizing Nucleic
Acids Combination Therapy
5 PAMAM Dendrimers as a Delivery System for Small Interfering
RNA
6 Delivery of Functional Small RNAs via Extracellular Vesicles In
Vitro and In Vivo
7 Optimized siRNA Delivery into Primary Immune Cells Using
Electroporation
8 Synthesis and Evaluation of Caged siRNAs with Single cRGD
Modiϐication for Photoregulating RNA Interference
9 Exploring 5′-Biotinylation of the Sense Strand to Improve siRNA
Speciϐicity and Potency
10 In Vivo Delivery of Cassettes Encoding Anti-HBV Primary
MicroRNAs Using an Ancestral Adeno-Associated Viral Vector
11 Generating DNA Expression Cassettes Encoding Multimeric
Artiϐicial MicroRNA Precursors
12 MiR-302-Mediated Somatic Cell Reprogramming and Method
for Generating Tumor-Free iPS Cells Using miR-302
13 Urinary MicroRNAs as Emerging Class of Noninvasive
Biomarkers
14 Improving Dendritic Cell Cancer Vaccine Potency Using RNA
Interference
15 Unleashing the Therapeutic Potential of Dendritic and T Cell
Therapies Using RNA Interference
16 Harnessing the Antiviral-Type Responses Induced by
Immunostimulator y siRNAs for Cancer Immunotherapy
17 Cancer Immunotherapy: Targeting Tumor-Associated
Macrophages by Gene Silencing
18 Use of RNA Interference with TCR Transfer to Enhance Safety
and Efϐiciency
19 CRISPR/ Cas9 Guide RNA Design Rules for Predicting Activity
20 CRISPR-Cas9 Genome Editing in Human Cell Lines with Donor
Vector Made by Gibson Assembly
21 Genome Editing in Zebraϐish Using High-Fidelity Cas9
Nucleases: Choosing the Right Nuclease for the Task
22 Next Generation of Adoptive T Cell Therapy Using CRISPR/ Cas9
Technology: Universal or Boosted?
23 Engineering T Cells Using CRISPR/ Cas9 for Cancer Therapy
24 CRISPR/ Cas9-Mediated Genome Engineering of Primary
Human B Cells
25 Gene Editing in B-Lymphoma Cell Lines Using CRISPR/ Cas9
Technology
26 Gene Knockout in Hematopoietic Stem and Progenitor Cells
Followed by Granulocytic Differentiation
27 CRISPR/ Cas9 Genome Editing of Human-Induced Pluripotent
Stem Cells Followed by Granulocytic Differentiation
Index

مشخصات فایل